IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 101, Issue 2, 1999, Pages 188-196

  Okuda, Yoshinobu ^a   Sakoda, Saburo ^a   Fujimura, Harutoshi ^a   Saeki, Yukihiko ^a   Kishimoto, Tadamitsu ^b   Yanagihara, Takehiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Cytokines; Experimental autoimmune encephalomyelitis; Knockout mouse; Myelin oligodendrocyte glycoprotein

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 6;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PASSIVE TRANSPORT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

ANIMALS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 0032700063     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00139-3     Document Type: Article

References (30)

1. Bansil S., Cook S.D., Rohowsky-Kochan C. Multiple sclerosis: immune mechanism and update on current therapies. Ann. Neurol. 37(S1):1995;87-101.
2. Bernard C.C.A., Johns T.G., Slavin A., Ichikawa M., Ewing C., Liu J., Bettadapura J. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75:1997;77-88.
3. Cua D.J., Hinton D.R., Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 155:1995;4052-4059.
4. Eugster H., Frei K., Kopf M., Lassmann H., Fontana A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;2178-2187.
5. Falcone M., Bloom B.R. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:1997;901-907.
6. Frei K., Fredrikson S., Fontana A., Link H. Interleukin-6 is elevated in plasma in multiple sclerosis. J. Neuroimmunol. 31:1991;147-153.
7. Gijbels K., Brocke S., Abrams J.S., Steinman L. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:1995;795-805.
8. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspect of interleukin 6. Immunol. Today. 11:1990;443-449.
9. Hjelmström P., Juedes A.E., Fjell J., Ruddle N.H. B cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:1998;4480-4483.
10. Kishimoto T. The biology of interleukin-6. Blood. 74:1989;1-10.
11. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:1994;339-342.
12. Lassmann H., Zimprich F., Rössler K., Vass K. Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev. Neurol. 147:1991;763-781.
13. Maimone D., Gregory S., Arnason B.G.W., Reder A.T. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 32:1991;67-74.
14. Maimone D., Guazzi G.C., Annunziata P. IL-6 detection in multiple sclerosis brain. J. Neurol. Sci. 146:1997;59-65.
15. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25:1995;1951-1959.
16. Mendel I., Katz A., Kozack N., Ben-Nun A., Revel M. Interleukin-6 function in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1998;1727-1737.
17. Navikas V., Matusevicius D., Söderström M., Fredrikson S., Kivisäkk P., Ljungdahl Å., Höjeberg B., Link H. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J. Neuroimmunol. 64:1996;63-69.
18. Nishimoto N., Yoshizaki K., Eiraku N., Machigashira K., Tagoh H., Ogata A., Kuritani T., Osame M., Kishimoto T. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Neurol. Sci. 97:1990;183-193.
19. Ohsima S., Saeki Y., Mima T., Sasai M., Nishioka K., Nomura S., Kopf M., Katada Y., Tanaka T., Suemura M., Kishimoto T. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8222-8226.
20. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
21. Okuda Y., Sakoda S., Bernard C.C.A., Yanagihara T. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an up-regulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J. Interferon Cytokine Res. 18:1998;415-421.
22. Okuda Y., Sakoda S., Yanagihara T. The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 87:1998;147-155.
23. Okuda Y., Sakoda S., Bernard C.C.A., Fujimura H., Saeki Y., Kishimoto T., Yanagihara T. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:1998;703-708.
24. Olsson T. Critical influence of cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268.
25. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1996;1345-1355.
26. Samoilova E.B., Horton J.L., Hilliard B., Liu T.T., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:1998;6480-6486.
27. Van der Veen R.C., Stohlman S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:1993;213-220.
28. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:1996;2271-2278.
29. Woodroofe M.N., Cuzner M.L. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine. 5:1993;583-588.
30. Yasukawa K., Saito T. A new system for the expression of human interleukin-6 in Escherichia coli. Biotechnol. Letters. 12:1990;419-424.